Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medivation Inc (NASDAQ:MDVN)

63.99
Delayed Data
As of Jul 29
 +1.50 / +2.40%
Today’s Change
26.41
Today|||52-Week Range
64.16
+32.37%
Year-to-Date
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter
Jul 29 / GuruFocus News - Paid Partner Content
What's in Store for these 5 Drug Stocks in Q2 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
Barbarian At The Gate: Medivation (MDVN)
Jul 29 / TheStreet.com - Paid Partner Content
3 Stocks That Turned $5,000 into $100,000 or More
Jul 17 / MotleyFool.com - Paid Partner Content
Sanofi Quarterly Earnings, Sales Slide, Reiterates Discipline on Medivation
Jul 29 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close62.49
Today’s open62.19
Day’s range62.10 - 64.16
Volume2,861,829
Average volume (3 months)3,193,165
Market cap$10.3B
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-15.48%
Earnings growth (this year)-29.45%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+32.76%
P/E ratio42.1
Price/Sales8.68
Price/Book11.75

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.85-1.21%
IDXXIDEXX Laboratories I...+0.58+0.62%
VRXValeant Pharmaceutic...-0.83-3.59%
ALKSAlkermes Plc+1.77+3.68%
Data as of 4:08pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$943.3M
Annual profit (last year)$244.7M
Net profit margin25.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts

Partner Offers

Search for Jobs